Payer and provider collaborations that improve quality outcomes in oncology

Managed Care

Volumn 19, Issue 11, 2010, Pages

  Dunn, Jeffrey D ^b   Ellis, Peter G ^c   Fox, John L ^d   Klein, Ira ^e   Lopes, Maria ^f   Nash, David B ^a   Nishida, Lynn ^g   Schwartzberg, Lee S ^h   Wong, Winston ⁱ  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b SelectHealth Inc   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d Medical Affairs   (United States)

^e AMCHealth ^*

^f AMC Health   (United States)

^g Clinical Pharmacy Services   (United States)

^h WEST CLINIC   (United States)

ⁱ Pharmacy Management   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78649940256     PISSN: 10623388     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (10)

1. ACS (American Cancer Society). Cancer Facts & Figures 2010. American Cancer Society. http://www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/cancer-facts-and-figures-2010. Accessed Oct. 10, 2010.
2. Eisenberg JM. Doctors' Decisions and the Cost of Medical Care. Ann Arbor, MI: Health Administration Press; 1986.
3. Gianni L, Zambetti M, Clark K, et al. Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer. J Clin Oncol. 2005;23(29):7265-7277.
4. Habel LA, Shak S, Jacobs MK, et al. A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. Breast Cancer Res. 2006;8(3):R25.
5. James BC. A conversation with Brent C James, MD. Health reform debate overlooks physician-patient dynamic. Manag Care. 2009;18(12):31-34.
6. IOM (Institute of Medicine). Initial national priorities for comparative effectiveness research. June 2009. «http://iom.edu/~/media/Files/Report%20Files/2009/ComparativeEffectivenessResearchPriorities/CER%20report%20brief%2008-13-09.ashx». Accessed Oct. 10, 2010.
7. NCCN (National Comprehensive Cancer Network). NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. V.2.2010. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed Oct. 10, 2010.
8. Paik S, Shak S, Tang G, Kim C, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351(27):2817-2826.
9. Paik S, Tang G, Shak S, et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptorpositivebreast cancer. J Clin Oncol. 2006; 24(23):3726-3734.
10. UPMC (University of Pittsburgh Medical Center). Pittsburgh, Pa. Data on file. 2010.